Concord Biotech Ltd.

BSE: 543960 | NSE: CONCORDBIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE338H01029 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Concord Biotec Concord Biotech Ltd. | BSE 1311.20 -35.45 (-2.63%) | NSE 1320.20 -25.40 (-1.89%) | Trade | Add

BSE Live

Jan 09, 16:01

1311.20 -35.45 (-2.63%)

Volume

AVERAGE VOLUME

5-Day

27,029

10-Day

14,499

30-Day

6,400

5,036

NSE Live

Jan 09, 15:56

1320.20 -25.40 (-1.89%)

Volume

AVERAGE VOLUME

5-Day

504,487

10-Day

280,124

30-Day

143,060

59,379

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Concord Biotech (in Rs. Cr.)	Mar 25	Mar 24
Per Share Ratios
Basic EPS (Rs.)	35.52	29.45
Diluted EPS (Rs.)	35.52	29.45
Cash EPS (Rs.)	40.85	34.25
Book Value [ExclRevalReserve]/Share (Rs.)	173.27	145.93
Book Value [InclRevalReserve]/Share (Rs.)	173.27	145.93
Revenue from Operations/Share (Rs.)	114.71	97.21
PBDIT/Share (Rs.)	52.65	44.48
PBIT/Share (Rs.)	47.45	39.36
PBT/Share (Rs.)	47.40	39.11
Net Profit/Share (Rs.)	35.65	29.13
NP After MI And SOA / Share (Rs.)	35.52	29.45
Profitability Ratios
PBDIT Margin (%)	45.89	45.75
PBIT Margin (%)	41.36	40.48
PBT Margin (%)	41.31	40.23
Net Profit Margin (%)	31.07	29.96
NP After MI And SOA Margin (%)	30.96	30.29
Return on Networth/Equity (%)	20.50	20.18
Return on Capital Employed (%)	26.82	26.41
Return on Assets (%)	18.26	18.11
Total Debt/Equity (X)	0.00	0.00
Asset Turnover Ratio (%)	0.64	0.63
Liquidity Ratios
Current Ratio (X)	6.17	6.30
Quick Ratio (X)	4.87	4.84
Inventory Turnover Ratio (X)	5.36	0.88
Dividend Payout Ratio (NP) (%)	24.63	23.19
Dividend Payout Ratio (CP) (%)	21.48	19.75
Earnings Retention Ratio (%)	75.37	76.81
Cash Earnings Retention Ratio (%)	78.52	80.25
Coverage Ratios
Interest Coverage Ratios (%)	1,040.58	182.35
Interest Coverage Ratios (Post Tax) (%)	1,040.58	182.35
Valuation Ratios
Enterprise Value (Cr.)	17,536.50	15,881.24
EV/Net Operating Revenue (X)	14.61	15.62
EV/EBITDA (X)	31.84	34.13
MarketCap/Net Operating Revenue (X)	14.61	15.66
Retention Ratios (%)	75.36	76.80
Price/BV (X)	9.67	10.43
Price/Net Operating Revenue	14.61	15.66
Earnings Yield	0.02	0.02